Karyopharm Therapeutics, Inc. (KPTI)
2.06
+0.19
(+10.16%)
USD |
NASDAQ |
Aug 31, 16:00
2.075
+0.02
(+0.73%)
After-Hours: 20:00
Karyopharm Therapeutics Cash and Short Term Investments (Quarterly) : 65.10M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 65.10M |
| March 31, 2026 | 90.85M |
| December 31, 2025 | 63.74M |
| September 30, 2025 | 45.88M |
| June 30, 2025 | 51.70M |
| March 31, 2025 | 69.94M |
| December 31, 2024 | 108.74M |
| September 30, 2024 | 133.56M |
| June 30, 2024 | 152.16M |
| March 31, 2024 | 149.04M |
| December 31, 2023 | 192.10M |
| September 30, 2023 | 208.86M |
| June 30, 2023 | 237.33M |
| March 31, 2023 | 261.23M |
| December 31, 2022 | 279.03M |
| September 30, 2022 | 149.46M |
| June 30, 2022 | 171.99M |
| March 31, 2022 | 206.32M |
| December 31, 2021 | 234.96M |
| September 30, 2021 | 206.61M |
| June 30, 2021 | 236.65M |
| March 31, 2021 | 225.18M |
| December 31, 2020 | 251.72M |
| September 30, 2020 | 264.13M |
| June 30, 2020 | 298.63M |
| Date | Value |
|---|---|
| March 31, 2020 | 353.12M |
| December 31, 2019 | 263.07M |
| September 30, 2019 | 267.53M |
| June 30, 2019 | 217.16M |
| March 31, 2019 | 264.42M |
| December 31, 2018 | 328.20M |
| September 30, 2018 | 206.77M |
| June 30, 2018 | 241.12M |
| March 31, 2018 | 130.92M |
| December 31, 2017 | 146.67M |
| September 30, 2017 | 119.61M |
| June 30, 2017 | 143.65M |
| March 31, 2017 | 110.08M |
| December 31, 2016 | 129.55M |
| September 30, 2016 | 126.81M |
| June 30, 2016 | 122.74M |
| March 31, 2016 | 136.42M |
| December 31, 2015 | 175.63M |
| September 30, 2015 | 195.24M |
| June 30, 2015 | 221.19M |
| March 31, 2015 | 246.41M |
| December 31, 2014 | 205.72M |
| September 30, 2014 | 227.13M |
| June 30, 2014 | 132.31M |
| March 31, 2014 | 144.89M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Madrigal Pharmaceuticals, Inc. | 838.91M |
| Relay Therapeutics, Inc. | 910.93M |
| ACADIA Pharmaceuticals, Inc. | 956.47M |
| Alnylam Pharmaceuticals, Inc. | 3.308B |
| Anika Therapeutics, Inc. | 38.41M |